Page 1289 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 1289

CHaPtEr 92  Flow Cytometry             1251


           29.  Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: defining   43.  Fleisher TA, Dorman SE, Anderson JA, et al. Detection of intracellular
             subgroups in common variable immunodeficiency. Blood   phosphorylated STAT-1 by flow cytometry. Clin Immunol
             2008;111:77–85.                                        1999;90:425–30.
           30.  Rosel AL, Scheibenbogen C, Schliesser U, et al. Classification of common   44.  Vowells SJ, Fleisher TA, Sekhsaria S, et al. Genotype-dependent variability
             variable immunodeficiencies using flow cytometry and a memory B-cell   in flow cytometric evaluation of reduced nicotinamide adenine
             functional assay. J Allergy Clin Immunol 2014;135:198–208.  dinucleotide phosphate oxidase function in patients with chronic
           31.  Bonilla FA, Barlan I, Chapel H, et al. International consensus document   granulomatous disease. J Pediatr 1996;128:104–7.
             (ICON): common variable immunodeficiency disorders. J Allergy Clin   45.  Heim KF, Fleisher TA, Stroncek DF, et al. The relationship between
             Immunol Pract 2016;4:38–59.                            alloimmunization and posttransfusion granulocyte survival: experience
           32.  Etzioni A. Defects in the leukocyte adhesion cascade. Clin Rev Allergy   in a chronic granulomatous disease cohort. Transfusion 2001;51:
             Immunol 2010;38:54–60.                                 1154–62.
           33.  Berliner N, Ault KA, Martin P, et al. Detection of clonal excess in   46.  Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and
             lymphoproliferative disease by kappa/lambda analysis: correlation with   survival in chronic granulomatous disease. N Engl J Med
             immunoglobulin gene DNA rearrangement. Blood 1986;67:80–5.  2010;363:2600–10.
           34.  Pilch H, Hohn H, Freitag K, et al. Improved assessment of T-cell receptor   47.  Foster B, Prussin C, Liu F, et al. Detection of intracellular cytokines by
             (TCR) VB repertoire in clinical specimens: combination of TCR- CDR3   flow cytometry. Curr Protoc Immunol 2007;Chapter 6:Unit 6.24.
             spectratyping with flow cytometry-based TCR VB frequency analysis.   48.  Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell
             Clin Diagn Lab Immunol 2002;9:257–66.                  cytokine expression in whole blood by flow cytometry. J Immunol
           35.  Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector   Methods 1998;212:89–98.
             memory T cell subsets: function, generation, and maintenance. Annu Rev   49.  Shankey TV, Rabinovitch PS, Bagwell B, et al. Guidelines for
             Immunol 2004;22:745–63.                                implementation of clinical DNA cytometry. International Society for
           36.  Avery DT, Ellyard JI, Mackay F, et al. Increased expression of CD27 on   Analytical Cytology. Cytometry 1993;14:472–7.
             activated human memory B cells correlates with their commitment to the   50.  Braylan RC, Benson NA, Nourse V, et al. Correlated analysis of cellular
             plasma cell lineage. J Immunol 2005;174:4034–42.       DNA, membrane antigens and light scatter of human lymphoid cells.
           37.  Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the   Cytometry 1982;2:337–43.
             identification of natural killer activity. J Immunol Methods   51.  Rothaeusler K, Baumgarth N. Assessment of cell proliferation by
             2004;294:15–22.                                        5-bromodeoxyuridine (BrdU) labeling for multicolor flow cytometry.
           38.  Marcenaro S, Gall F, Martini S, et al. Analysis of natural killer-cell   Curr Protoc Cytom 2007;Chapter 7:Unit 7.31.
             function in familial hemophagocytic lymphohistiocytosis (FHL): defective   52.  Gong J, Bhatia U, Traganos F, et al. Expression of cyclins A, D2 and D3 in
             CD107a surface expression heralds Munc13-4 defect and discriminates   individual normal mitogen stimulated lymphocytes and in MOLT-4
             between genetic subtypes of the disease. Blood 2006;108:2316–23.  leukemic cells analyzed by multiparameter flow cytometry. Leukemia
           39.  Mardiney M 3rd, Brown MR, Fleisher TA. Measurement of T-cell CD69   1995;9:893–9.
             expression: a rapid and efficient means to assess mitogen- or   53.  Telford WG, Komoriya A, Packard BZ, et al. Multiparametric analysis of
             antigen-induced proliferative capacity in normals. Cytometry   apoptosis by flow cytometry. Methods Mol Biol 2011;699:203–27.
             1996;26:305–10.                                      54.  Altman JD, Moss PA, Goulder PJ, et al. Phenotypic analysis of
           40.  Allsopp CE, Langhorne J. Assessing antigen-specific proliferation and   antigen-specific T lymphocytes. Science 1996;274:94–6.
             cytokine responses using flow cytometry. Methods Mol Med   55.  Mallone R, Nepom GT. MHC Class II tetramers and the pursuit of
             2002;72:409–21.                                        antigen-specific T cells: define, deviate, delete. Clin Immunol
           41.  Slezak SE, Horan PK. Cell-mediated cytotoxicity. A highly sensitive and   2004;110:232–42.
             informative flow cytometric assay. J Immunol Methods 1989;117:205–14.  56.  Kern F, LiPira G, Gratama JW, et al. Measuring Ag-specific immune
           42.  Yu Y, Arora A, Min W, et al. EdU incorporation is an alternative non-   responses: understanding immunopathogenesis and improving
             radioactive assay to [(3)H]thymidine uptake for in vitro measurement of   diagnostics in infectious disease, autoimmunity and cancer. Trends
             mice T-cell proliferations. J Immunol Methods 2009;350:29–35.  Immunol 2005;26:477–84.
   1284   1285   1286   1287   1288   1289   1290   1291   1292   1293   1294